Reversible Pulmonary Arterial Hypertension Associated with Interferon-Beta Treatment for Multiple Sclerosis
Interferon (IFN) therapy has an important role in the treatment of multiple sclerosis and chronic hepatitis C infection. A few case reports have described an association between IFN therapy and the development of irreversible pulmonary arterial hypertension (PAH), and it is currently listed as a pos...
Main Authors: | E Gibbons, S Promislow, RA Davies, G Chandy, DJ Stewart, V Contreras-Dominguez, C Pugliese, R Dunne, LM Mielniczuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2015/181535 |
Similar Items
-
Beta-interferons in multiple sclerosis
by: Aggarwal Sourabh, et al.
Published: (2010-01-01) -
Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity
by: Anastasia Anthi, et al.
Published: (2020-03-01) -
Neutralising antibodies to interferon beta in multiple sclerosis
by: Farrell, R. A.
Published: (2010) -
INTERFERON BETA 1B FOR THE IMMUNOMODULATORY TREATMENT OF MULTIOCULAR SCLEROSIS IN PEDIATRIC NEUROLOGIC PRACTICES
by: O.V. Bykova, et al.
Published: (2006-12-01) -
INTERFERON BETA 1B FOR THE IMMUNOMODULATORY TREATMENT OF MULTIOCULAR SCLEROSIS IN PEDIATRIC NEUROLOGIC PRACTICES
by: O.V. Bykova, et al.
Published: (2006-12-01)